Cynata Therapeutics Limited
CYP.AX
Australian Securities Exchange0.02
AUD
+0.00
- -
Total Valuation
Cynata Therapeutics Limited carries a market capitalization of 3.90M, placing it among publicly traded companies globally.
| Market Cap | 3.90M |
| Enterprise Value | N/A |
Stock Price Statistics
Cynata Therapeutics Limited's stock has declined approximately -89.67742% over the past 52 weeks. The 50-day moving average sits at 0.23, while the 200-day moving average is 0.28.
| Beta (5Y) | N/A |
| 52-Week Price Change | -89.67742% |
| 50-Day Moving Average | 0.23 |
| 200-Day Moving Average | 0.28 |
| Average Volume (20 Days) | N/A |
Stock Splits
Cynata Therapeutics Limited's most recent stock split took place on October 31, 2013 with a 20:1 split ratio.
| Last Split Date | 10/31/2013 |
| Split Ratio | 20:1 |